Publications

June 2024
Article

Redistributive Allocation Mechanisms

By: Mohammad Akbarpour, Piotr Dworczak and Scott Duke Kominers

Many scarce public resources are allocated at below-market-clearing prices, and sometimes for free. Such "non-market" mechanisms sacrifice some surplus, yet they can potentially improve equity. We develop a model of mechanism design with redistributive concerns. Agents... View Details

Keywords: Equality and Inequality; Welfare; Mathematical Methods; Market Design; Cost vs Benefits

SSRN

May 2024
Background Note

Net Revenue Retention: Unpacking the Dynamics of Customer Monetization

By: Elie Ofek, Barak Libai and Eitan Muller

Firms and investors alike are beginning to recognize the importance of tracking how revenues from existing customers are evolving over time and to appreciate the value in understanding what might explain changes in these revenues. Consequently, in addition to looking... View Details

Keywords: Customer Relationship Management; Revenue; Measurement and Metrics; Customer Value and Value Chain

May 2024
Case

HarvEast

By: Jeremy Friedman and Natalie Kindred

In late 2023, Dmitry Skornyakov, CEO of Ukrainian agribusiness HarvEast, was navigating the turmoil caused by Russia’s invasion of Ukraine that began in 2014 and escalated into full-scale war in February 2022. Before the full-scale invasion, HarvEast managed 127,000... View Details

Keywords: Goods and Commodities; Natural Resources; Food; Problems and Challenges; Adaptation; Innovation and Management; Crisis Management; Logistics; Supply Chain; Risk and Uncertainty; Loss; Trust; Human Needs; War; Agriculture and Agribusiness Industry; Chile; South America; Latin America; Ukraine

2024
Working Paper

Does the Case for Private Equity Still Hold?

By: Nori Gerardo Lietz and Philipp Chvanov

Private Equity (“PE”) received a 10-fold increase in capital flows since the Great Financial Crisis (“GFC”) Investors sought higher nominal returns relative to those they could obtain in the public capital markets. This paper questions the fundamental assumptions... View Details

Keywords: Private Equity; Investment Return; Investment Portfolio; Financial Markets

SSRN

April 2024 (Revised July 2024)
Case

Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs

By: Joseph L. Badaracco, Tom Quinn and John Schultz

Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details

2024
Working Paper

Valuing Stocks With Earnings

By: Sebastian Hillenbrand and Odhrain McCarthy

We show that commonly used aggregate earnings are several times as volatile as stock prices over the last three decades. Movements in the price-earnings ratio are thus entirely explained by earnings growth and unrelated to future returns. As an alternative to the... View Details

Keywords: Price; Investment Portfolio; Stocks; Behavioral Finance; Accounting

SSRN

March 2024 (Revised May 2024)
Case

Amperity: First-Party Data at a Crossroads

By: Elie Ofek, Hema Yoganarasimhan and Alexis Lefort

In the summer of 2023, Amperity management was facing a critical decision on its future direction. Given the dramatic changes occurring within the digital advertising ecosystem, as concerns over consumer privacy placed limits on the ability to engage in third-party... View Details

Keywords: AI and Machine Learning; Technology Adoption; Business Strategy; Digital Marketing; Price; Product; Business or Company Management; Advertising Industry

March 2024
Article

Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act

By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti

The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that... View Details

Keywords: Policy; Government Legislation; Health Care and Treatment; Negotiation; Price; Pharmaceutical Industry

Find at Harvard

February 26, 2024
Article

Making Workplaces Safer Through Machine Learning

By: Matthew S. Johnson, David I. Levine and Michael W. Toffel

Machine learning algorithms can dramatically improve regulatory effectiveness. This short article describes the authors' scholarly work that shows how the U.S. Occupational Safety and Health Administration (OSHA) could have reduced nearly twice as many occupational... View Details

Keywords: Government Experimentation; Auditing; Inspection; Evaluation; Process Improvement; Government Administration; AI and Machine Learning; Safety; Governing Rules, Regulations, and Reforms

February 2024
Case

Oak Street Health: From Start-up to Strategic Acquisition

By: Leemore S. Dafny and Thomas H. Lee

Oak Street Health opened its first primary care center for seniors in underserved communities in 2013. By 2022 the company had 169 centers and a market valuation exceeding $10 billion. Oak Street created value by accepting risk-adjusted, capitated payments for Medicare... View Details

Keywords: Value Creation; Mergers and Acquisitions; Business Strategy; Health Industry

February 2024
Teaching Note

Accelerating with Caution: Forecasting and Managing birddogs' Growth (A) and (B)

By: Mark Egan

Teaching Note for HBS Case Nos. 224-023 and 224-024. As 2017 was drawing to a close, birddogs’ founder and CEO, Peter Baldwin, was working with his CFO Jack Sullivan to prepare for 2018. A nascent direct-to-consumer apparel brand, birddogs had carved its niche in men’s... View Details

Keywords: Inventory Management; Forecasting Demand; Financial Constraints; Apparel; Startups; Corporate Finance; Forecasting and Prediction; Working Capital; Financing and Loans; Organizational Change and Adaptation; Demand and Consumers; Apparel and Accessories Industry; United States

February 2024
Case

Compass Pathways: Pioneering Psychedelic Treatment

By: Tiona Zuzul, Kisha Lashley and Gamze Yucaoglu

This case follows Compass Pathways, a pioneering company developing treatment for depression based on psilocybin, the compound found in ‘magic mushrooms.’ Psilocybin was a federally illegal substance in the U.S., and a “Schedule I” drug, defined as a drug “with no... View Details

Keywords: Commercialization; Corporate Strategy; Competitive Strategy; Product Launch; Health Testing and Trials; Research and Development; Laws and Statutes; Pharmaceutical Industry; Europe; United States; United Kingdom

January 2024 (Revised October 2024)
Case

DO & CO: Crafting Luxury in the Fast Lane (A)

By: Juan Alcácer, Esel Cekin, Michael Lee and Noah Roberson

In July 2023, Attila Dogudan, the chairman of DO & CO, a renowned international catering firm, found himself in a deep conversation with his two sons about a potential new venture: catering for the Las Vegas Grand Prix, a significant step beyond their 31-year history... View Details

Keywords: Decision Choices and Conditions; Health Pandemics; Opportunities; Corporate Strategy; Luxury; Food and Beverage Industry; Las Vegas

January 2024 (Revised June 2024)
Case

School of Rock: Tuning into Structured Empowerment (A)

By: Tatiana Sandino, Jeffrey Rayport, Samuel Grad and Stacy Straaberg

In summer 2021, School of Rock was a youth-oriented music education company with 291 franchise- and company-owned schools globally. Before CEO Rob Price’s hire in 2017, School of Rock’s nonconformist rock ‘n’ roll culture led to variability in teaching styles,... View Details

January 2024 (Revised March 2024)
Case

Tesla Motors in 2024--Turbulence Ahead?

By: Felix Oberholzer-Gee and Kate Stoppiello

Over its 20 years in existence, Tesla had become nearly synonymous with electric vehicles, and the company assumed an enviable market position. By 2023, however, Tesla faced intense competition. Traditional carmakers and EV upstarts were expected to introduce close to... View Details

Keywords: Competitive Strategy; Product Positioning; Competition; Industry Growth; Auto Industry; North America; Europe; China; Australia

January 2024 (Revised May 2024)
Case

Pioneer Natural Resources: Enhancing the Capital Return Strategy with Variable Dividends

By: Benjamin C. Esty, Elisabeth Kempf and E. Scott Mayfield

In February 2021, Scott Sheffield, the CEO of Pioneer Natural Resources (an independent oil and gas company based in Texas), was considering the possibility of enhancing the firm’s capital return strategy by introducing a variable dividend tied to cash flows in... View Details

Keywords: Corporate Finance; Cash Flow; Financial Management; Financial Strategy; Value Creation; Decision Choices and Conditions; Investment Return; Profit; Policy; Business and Shareholder Relations; Energy Industry; United States; North America; Texas